\begin{table}[htbp]
\centering
\caption{CPIC Guideline Recommendations for CYP2D6 Substrates (Abbreviated)}
\label{tab:ch17-cpic-summary}
\small
\begin{tabular}{p{0.18\textwidth}p{0.18\textwidth}p{0.25\textwidth}p{0.25\textwidth}}
\toprule
\textbf{Drug Class} & \textbf{Phenotype} & \textbf{Recommendation} & \textbf{Rationale} \\
\midrule
\textbf{Codeine / Tramadol} & Poor Metabolizer & Avoid; use alternative analgesic & No conversion to active metabolite; ineffective \\
& Intermediate & Consider reduced dose or alternative & Reduced efficacy likely \\
& Normal & Standard dosing & Expected response \\
& Ultrarapid & \textbf{Avoid; contraindicated} & Risk of toxicity, respiratory depression, death \\[6pt]

\textbf{Tricyclic Antidepressants} & Poor Metabolizer & Avoid or reduce dose by 50\%; monitor TDM & High risk of toxicity \\
& Intermediate & Reduce dose by 25\%; monitor TDM & Increased AUC \\
& Normal & Standard dosing & Expected response \\
& Ultrarapid & Consider increased dose or alternative & Rapid clearance; potential treatment failure \\[6pt]

\textbf{SSRIs (paroxetine)} & Poor Metabolizer & Reduce dose by 50\%; monitor for ADRs & $\sim$5$\times$ AUC increase \\
& Normal & Standard dosing & Expected response \\
& Ultrarapid & Consider alternative SSRI & Subtherapeutic levels \\[6pt]

\textbf{Venlafaxine} & Poor Metabolizer & Avoid or reduce dose & Reduced conversion to active metabolite \\
& Ultrarapid & Consider increased dose or alternative & Rapid metabolism \\
\bottomrule
\end{tabular}
\end{table}